Heart failure & cardiomyopathies

Electronic Nudges to Increase Influenza Vaccination Uptake Among Patients with Heart Failure: A Pre-Specified Analysis of the NUDGE-FLU Trial

Eur J Heart FailPublished Secondary analysis of the NUDGE-FLU randomised trial

Authors' conclusion

HF status did not modify the effectiveness of cardiovascular gain-framed and repeated electronic nudging letters in increasing influenza vaccination rates.

Study context

Population
Danish citizens ≥65 years with heart failure (HF) at baseline (NUDGE-FLU); overall Danish HF population incl. <65 yearswith HF at baseline
Participants
33,109 participants
Comparison
Electronic nudging letters vs usual care in patients with HF
Primary endpoint
Receipt of an influenza vaccine
Methodological detailspre-specified analysis, nationwide
  • Pre-specified analysis
  • Nationwide

Primary result

As reported in the abstract

Effect modification of nudges on vaccination by HF status
HF status did not modify effect of cardiovascular gain-framed letter
pinteraction = 0.37
HF status did not modify effect of repeated letter
pinteraction = 0.55

Further findings

Vaccination uptake by baseline GDMT level

P < 0.001

Influenza vaccination uptake, overall Danish HF population (2022-2023 season)

Uptake, overall HF population (n = 65 075)
71.6%
Uptake, <65 years
44.6%

Effect modification by guideline-directed medical therapy (GDMT) use level

No effect modification for repeated letter
P for interaction = 0.88
Trend towards attenuated effect of cardiovascular gain-framed letter with low GDMT
P for interaction = 0.07

Longitudinal GDMT use

Letters had no impact on longitudinal GDMT use

Original publication

Electronic Nudges to Increase Influenza Vaccination Uptake Among Patients with Heart Failure: A Pre-Specified Analysis of the NUDGE-FLU Trial. Eur J Heart Fail. Published 4 June 2023. doi:10.1002/ejhf.2913

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.